Cargando…
Pharmacological Inhibition of miR-130 Family Suppresses Bladder Tumor Growth by Targeting Various Oncogenic Pathways via PTPN1
Previously, we have revealed that the miR-130 family (miR-130b, miR-301a, and miR-301b) functions as an oncomiR in bladder cancer. The pharmacological inhibition of the miR-130 family molecules by the seed-targeting strategy with an 8-mer tiny locked nucleic acid (LNA) inhibits the growth, migration...
Autores principales: | Monoe, Yuya, Jingushi, Kentaro, Kawase, Akitaka, Hirono, Takayuki, Hirose, Ryo, Nakatsuji, Yoshino, Kitae, Kaori, Ueda, Yuko, Hase, Hiroaki, Abe, Yuichi, Adachi, Jun, Tomonaga, Takeshi, Tsujikawa, Kazutake |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124864/ https://www.ncbi.nlm.nih.gov/pubmed/33947152 http://dx.doi.org/10.3390/ijms22094751 |
Ejemplares similares
-
The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN
por: Egawa, Hiroshi, et al.
Publicado: (2016) -
MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2
por: Hirono, Takayuki, et al.
Publicado: (2019) -
ALKBH4 is a novel enzyme that promotes translation through modified uridine regulation
por: Kogaki, Takahiro, et al.
Publicado: (2023) -
AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells
por: Ueda, Yuko, et al.
Publicado: (2017) -
ALKBH4 promotes tumourigenesis with a poor prognosis in non-small-cell lung cancer
por: Jingushi, Kentaro, et al.
Publicado: (2021)